Clinical Trials Directory

Trials / Unknown

UnknownNCT02444962

BioComp Implants in Anaplastology - Pilot Study

Safe and Easy Application of BioComp Implants for Prosthetic Reconstruction of Craniofacial Defects

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

At the department of Cranio-Maxillofacial Surgery, Maastricht University Medical Center (MUMC) the routine procedure after ablation of the nose, ear or eye is reconstruction with an episthesis. Retention can be achieved using adhesives, undercuts or bone implants. Implant based episthesis are now commonly used because of the good retention and episthesis stability. This results in a better patient quality of life. Today we use machined surface implants in the craniofacial region of different brands. Each system has its own instruments and application method. To enhance the clinical usability, we are searching for one system for all extra-oral implant regions. Furthermore, implant patients may be compromised by aging, diseases, smoking, medication and radiation therapy, which can affect the bone healing process. In these cases, implants are known to have higher failure rates compared to the application in healthy cases. Therefore implants with biomechanical surface modifications, such as the HAVD implants of BioComp, may have a positive effect on osseointegration, resulting in higher success rates in the compromised patient. The aim of this pilot study is to collect information about the functionality and safety of a surface treated implant system (HAVD, BioComp) for episthetic reconstruction after ablative surgery in the nasal, orbital and auricular region for a potential future RCT.

Conditions

Interventions

TypeNameDescription
DEVICEHAVD-implanthydroxy-apatite coated, acid etched implant for extra oral use to reconstruct craniofacial defects with an episthesis

Timeline

Start date
2018-06-01
Primary completion
2019-12-31
Completion
2020-12-31
First posted
2015-05-15
Last updated
2018-11-27

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT02444962. Inclusion in this directory is not an endorsement.